Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NETZSCH Earns a Prestigious R&D 100 Award

Published: Tuesday, July 09, 2013
Last Updated: Tuesday, July 09, 2013
Bookmark and Share
New instrument is designed to test the performance and safety of Large Format Li-Ion Batteries.

NETZSCH Instruments North America, LLC (NETZSCH) has announced that the new Isothermal Battery Calorimeter IBC 284 284 developed based on National Renewable Energy Laboratory’s technology has been named among this year’s most significant innovations by R&D Magazine.

Known in the research and development community as “the Oscars of Innovation”, the R&D 100 Awards provide a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovative ideas of the year.

The need for better performing and safer batteries created a market opportunity for instrumentation designers in battery development.

With this in mind, NETZSCH approached the Energy Department’s National Renewable Energy Laboratory (NREL), a leader in battery calorimetry technology, to develop a better way to detect heat loss in electric-vehicle batteries.

“With forecasts of more than half a million hybrid and electric cars this year - and with manufacturers needing to meet the regulated increased fuel efficiency - we saw a real gap in the marketplace for accurate testing of the larger battery systems” stated Dr. Gilles Widawski, President of NETZSCH Instruments North America, LLC.

Dr. Widawski continued, “The IBC 284 allows auto manufacturers to address safety and efficiency issues long before drivers have to rely on battery packs to get them back home. NREL has been working on battery thermal testing and calorimetry for over 15 years and the R&D Award is a fantastic recognition of their work.”

The new instrument is designed to test the performance and safety of Large Format Li-Ion Batteries used extensively in electric vehicles, airplanes, and military applications, as well as stationary power back-up and storage applications.

The instrumentation is able to safely and accurately characterize heat output and efficiency of the batteries under varying temperature, pressure, load and use conditions, providing precise and critical information previously unavailable.

Temperature has a strong impact on the performance, safety, and life of batteries. Temperature control is necessary to successfully operate lithium ion batteries, particularly for electric drive vehicles, which will play a critical role in lowering dependence on imported oil and air pollution.

The IBC’s patent-pending innovations-complete thermal isolation, the ability to test large cells and batteries, and the features needed to test high energetic batteries safely-provide a level of accuracy and functionality not seen in other calorimeters.

The ability to precisely measure heat generation helps to optimize battery thermal-management systems and to both extend battery life and improve safety at an affordable cost.

The NETZSCH team included Peter Ralbovsky, Jean-Francois Mauger, and Gilles Widawski. NREL’s Isothermal Battery Calorimeters team included Matt Keyser, Ahmad Pesaran, John Ireland, Dirk Long, and Mark Mihalic.

51st Year of Awards for Innovation
Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market. Many of these have become household names, helping shape everyday lives.

Winners of the R&D 100 Awards are selected by an independent judging panel and the editors of R&D Magazine. The publication and its online portal serve research scientists, engineers, and other technical staff members at high-tech industrial companies and public and private laboratories around the world.

Winners will be recognized at the R&D 100 Awards Ceremony to be held in Orlando on Nov. 7, 2013. A full list of this year’s winners is available at www.rdmag.com.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Refining DSC Curves
Differential Scanning Calorimetry (DSC) is a method which determines the difference in heat flow between a sample and a reference. A closer look at the resulting curve, however, makes it clear that the temperature behavior and peak characteristics shown are not a true reflection of the sample behavior. In order to correct this distortion, NETZSCH has developed the “Tau-R Mode”.
Thursday, November 04, 2010
NETZSCH invests € 1.8 M into its Selb location
The groundbreaking for the construction of a new annex on May 28 marks the opening of a new chapter in NETZSCH-Gerätebau’s almost 50-year history.
Thursday, July 01, 2010
Engineering Safety into Highly Critical Components
Thermal conductivity and diffusivity are thermophysical material parameters necessary for describing the heat transport properties of a material or component. These physical parameters are the basis for accurate thermotechnical simulations or for the analysis of temperature fields in components for electronic assemblies, power plant turbines or drive units.
Thursday, March 25, 2010
New Management Team at NETZSCH-Geratebau GmbH
Dr. Otto Max Schaefer has resigned from his interim task as Managing Director and has now turned his full concentration in the management.
Wednesday, July 23, 2008
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!